PURPOSE. Endoplasmic reticulum (ER) stress has been demonstrated to contribute to neurodegeneration in multiple ocular diseases. However, whether ER stress can induce vascular degeneration in the retina remains unknown. We investigated the possible role of ER stress in retinal vascular degeneration in vivo, and the effects of resveratrol on tunicamycin and ischemia and reperfusion (I/R)-induced retinal vascular degeneration.
R
etinal ischemia is one of the causative factors in various ocular diseases, including acute close-angle glaucoma and diabetic retinopathy. 1 Vascular and neuronal degeneration observed in these diseases are the key histological hall-markers that contribute to retinal dysfunction and vision loss in patients. [2] [3] [4] [5] Retinal ischemia and reperfusion (I/R) injury is a commonly used in vivo model to mimic neuronal and vascular degeneration. 4, 6, 7 Through this model, the mechanisms underlying these degenerations and the therapies preventing the degenerations are studied.
One mechanism that contributes to the development of neuronal degeneration in the retina is endoplasmic reticulum (ER) stress. Upon accumulation of unfolded or misfolded proteins, ER activates three branches of adaptive responses to maintain cellular homeostasis and promote cell survival (see reviews 8, 9 ). However, when the protein folding ability cannot match the demand, ER stress is triggered and ER stressdependent apoptotic pathway is evoked. 10, 11 Elevation of ER stress has been found in multiple animal models of retinal diseases, including retinitis pigmentosa, 12 glaucoma, 13, 14 and diabetic retinopathy. [15] [16] [17] The critical role of ER stress in neurodegeneration in the retina also is demonstrated. Retinal neurodegeneration, which was characterized by ganglion cell loss and reduction of retinal thickness, has been observed after intravitreal injection of ER stress inducer, such as tunicamycin. 18, 19 Mice that are deficient in CCAAT enhancer-binding protein homologous protein (CHOP), a transcription factor mediating ER stress-dependent cell death, are resistant to Nmethyl-D-aspartic acid (NMDA)-induced retinal neurodegeneration. 20 However, whether ER stress also contributes to vascular degeneration in the retina is not known yet.
Resveratrol (trans-3,5,4 0 -trihydroxystilbene), abundantly found in grape skins, 21 is a natural polyphenolic phytoalexin with multiple bioactivities, including anti-oxidative 22, 23 and anti-inflammatory 24, 25 effects. The protective effects of resveratrol in several ocular diseases, including light/oxygen-induced retinopathy, 26, 27 endotoxin-induced uveitis, 24 and diabetic retinopathy, 28 have been demonstrated. However, the information on whether resveratrol could elicit protective effects on retinal I/R-induced neurovascular degeneration is lacking.
We investigated ER stress inducer tunicamycin-induced retinal vascular degeneration. The roles of resveratrol on tunicamycin or retinal I/R-induced ER stress and retinal vascular degeneration were evaluated. The results demonstrated that intravitreal injection of tunicamycin triggered ER stress in whole retina and retinal vasculature, and subsequentinduced capillary degeneration. Resveratrol inhibited tunicamycin and retinal I/R-induced capillary degeneration and overexpression of ER stress makers. Our findings uncovered a possible role of ER stress in retinal vascular degeneration, and a new therapeutic role of resveratrol on retinal vascular dysfunction.
MATERIALS AND METHODS

Animals
C57BL/6 mice were obtained from Wuhan University Animal Laboratory, and housed in ventilated microisolater cages with free access to water and food. All procedures involving the animals conformed to the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research, and approved by the Committee on Ethics in the Care and Use of Laboratory Animals of Wuhan University.
Retinal I/R Model and Resveratrol Administration
Retinal I/R was induced as previously reported. 4, 7 Briefly, after pupil dilation, the anterior chamber of one eye in the mouse was cannulated with a 33-gauge needle connected to a reservoir containing 0.9% NaCl. Pressure in the eye was increased to 80-90 mmHg with a pressure infuser (Infu-surg; Ethox Corp., Buffalo, NY). The duration of ischemia was 60 minutes. Retinal ischemia was confirmed by whitening of the iris and the fundus under microscopic observation. After ischemia, the needle was withdrawn and retinal circulation was reflowed. The other non-injured eye of the same animal served as the control. A sham operation without elevation of the pressure was done in some mouse eyes for comparison with the non-injured ones. The results demonstrated that the ER stress markers were expressed similarly in the sham operated retinas compared to that in the non-injured retinas (Figs. S1A, S1B, http://www.iovs.org/ lookup/suppl/doi:10.1167/iovs.11-8406/-/DCSupplemental). Two days before I/R injury, mice were pretreated with resveratrol (TCM Institute of Chinese Materia Medica, Nanjing, China) in diets at dosages of 5 mg/kg body weight (BW, low) and 25 mg/kg BW (high) per day. Retinas or eyeballs of different groups were collected 3 hours, and 1, 4, and 7 days after the injury for different analyses.
Tunicamycin Injection and Resveratrol Administration
Tunicamycin (Alexis Biochemicals, San Diego, CA) was dissolved in dimethylsulfoxide. Different dosages (0.1, 1, and 1.5 lg) of tunicamycin were injected into the vitreous of mouse eyes after anesthetization, and dimethylsulfoxide was injected as vehicle. As for resveratrol treatment in this model, 100 lM resveratrol together with 0.1 lg tunicamycin were injected into the vitreous. Retinas were harvested 1, 2, and 7 days after injection for different analyses.
Examination of Capillary Degeneration
Retinal vasculatures were isolated and quantitated as we reported previously. 4 Briefly, seven days after retinal I/R injury, pure retinal vasculatures were isolated with a trypsin digestion manner. Isolated vascular trees were stained with PAS and hematoxylin (PASH) for light microscopy examination (200· magnification). Acellular (degenerate) capillaries were identified as capillary-sized vessel tubes without nuclei along their length, and quantitated and reported as number per square millimeter of retinal area.
CHOP Immunofluorescence Staining on Retinal Vasculatures
One day after retinal I/R injury or two days after tunicamycin injection, eyeballs were enucleated and fixed in 4% formalin for 30 minutes. Retinas then were isolated and washed with distilled water, followed by digestion with 0.3% trypsin solution (Becton, Dickinson and Company, Sparks, MD) for 3 minutes. Vasculatures were isolated carefully and mounted onto slides. After permeabilization with 2% Triton X-100 (Amresco, Solon, OH), vasculatures were blocked with 5% BSA (Amresco) and incubated with anti-CHOP (1:100 dilution, Santa Cruz, CA) at 48C overnight. After extensive washing, vasculatures were incubated with tetramethyl rhodamine iso-thiocyanate (TRITC)-labeled anti-rabbit IgG (1:200 dilution; Dako, Denmark) for 1 hour at room temperature. Anti-fading mounting solution containing DAPI (Beyotime Biotech, Jiangsu, China) was added to the vasculatures, and images were taken under the fluorescence microscopy. Negative control was set up in parallel without applying primary antibody.
Morphologic Analysis and Quantitation of Cell Bodies in Retinal Ganglion Cell Layer (GCL)
Four days after retinal I/R injury, eyeballs routinely were fixed, embedded, cut, and stained with PASH. No retinal detachment was observed on retinal sections of any experimental groups. The nuclei in GCL (not including nuclei in the vessels) were counted. The result was reported as number of nuclei in GCL per 250 lm of retinal surface as reported previously. 4, 7 Brain-Specific Homeobox/POU Domain Protein 3A (Brn3a) Immunofluorescence Staining Four days after retinal I/R injury, retinal flat-mounts were freshly isolated. After brief fixation in 4% formalin at room temperature, flatmounts were washed and treated with 2% Triton X-100 for 15 minutes, then the immunostaining was performed using MOM kit (Vector Laboratory, Burlingame, CA) with anti-Brn3a (1:100 dilution; Millipore, Temecula, CA) and Alexa Fluor 488 labeled anti-mouse IgG (1:300 dilution; Invitrogen, Carlsbad, CA). After extensive washing, anti-fading mounting solution containing DAPI (Beyotime Biotech) was added to the samples. Images were taken under confocal microscope (Olympus, FV1000) at multiple magnifications (40·, 100·, and 600·). Brn3a þ cells in 20-30 different areas (600· magnification) of each retina were counted and reported per square millimeter of retinal area.
RNA Isolation and RT-PCR
Total RNA was isolated from retina using RNAiso Plus (TaKaRa Biotechnology, Dalian, China). Total RNA (1 lg) was reverse transcribed into cDNA using M-MLV first strand synthesis system (Invitrogen). The abundance of specific gene transcripts was assessed by PCR. The primer sequences were listed in supplementary Table S1 (http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-8406/-/ DCSupplemental). PCR products were separated by electrophoresis using 1.5% agarose gels, and images were photographed by Molecular Imager Gel Doc XR (Bio-Rad, Hercules, CA). Band density was quantified using Quantity One 1-D Analysis Software (Bio-Rad). mRNA levels were quantitated first against 18S rRNA levels in the same sample, then normalized to non-injured group, which was set up as 1-fold, with the exception that Xbp1 splicing was reported as the ratio of spliced Xbp1(Xbp1s)/total Xbp1(Xbp1t).
Western Blot Analysis
Retinas were isolated and sonicated in RIPA buffer (Beyotime Biotech, China). A total of 20-40 lg proteins per sample were separated by SDS-PAGE and electroblotted onto PVDF membrane (Millipore). After blocking, antibodies for p-eIF2a (CST, Danvers, MA), total-eIF2a (CST), CHOP (Epitomics, Burlingame, CA), Immunoglobulin binding protein (Bip; BD Transduction Laboratories, Franklin Lakes, NJ), inositol requiring enzyme 1a (IRE1a; CST), phospho-C-jun N-terminal kinase (JNK)1/2 (CST), total-JNK1/2 (CST), and b-actin (Sigma, St. Louis, MO) were applied overnight at 48C. All blots were washed and incubated with respective secondary antibody (Bio-Rad). Protein bands detected by the antibodies were visualized by ECL reagent (Millipore) following exposure on X-OMAT film. Protein expression levels were quantitated by the Quantity One 1-D Analysis Software (Bio-Rad) as we reported previously. 4, 7 The protein levels, except for the phosphorylated proteins, first were quantitated relative to b-actin in the same sample, and then the relative protein expression levels in different groups were normalized to the non-injured group, which set up as 1-fold. The levels of the phosphorylated proteins were quantitated first relative to their corresponding total protein levels in the same sample, and then the relative phosphorylated protein expression levels in different groups were normalized to the non-injured group, which was set up as 1-fold.
Statistical Analysis
All results were expressed as the mean 6 SD. Data were analyzed by the nonparametric Kruskal-Wallis test followed by the Mann-Whitney U test. Differences were considered statistically significant when P < 0.05. The changes were considered as trends when 0.05 < P 0.08 also were reported.
RESULTS
Resveratrol Inhibits Tunicamycin-Induced Vascular Degeneration in the Retina
Morphology of the vascular tree for the vehicle-injected retinas was as normal as that for the non-injected retinas (data not shown). However, seven days after tunicamycin injection, there was a dramatic increase in formation of completed degenerated capillaries (acellular capillaries), and ongoing degenerating capillaries (condensed and fragmental-like nuclei within capillary tubes) in the tunicamycin-injected retinas (Fig. 1A) . In retinas injected with 0.1, 1, and 1.5 lg tunicamycin, there were 32.7 6 11.9, 121.8 6 17.7, and 190.0 6 34.9 acellular capillaries per mm 2 retina, compared to 3.0 6 0.4 acellular capillaries per mm 2 in the vehicle injected retinas (P ¼ 0.01, Fig. 1B ). Moreover, 100 lM resveratrol significantly inhibited the formation of acellular capillary induced by 0.1 lg tunicamycin (P < 0.01). No significant differences in the formation of acellular capillaries were found between vehicle-injected retinas and non-injected retinas (Fig. 1B) .
Resveratrol Inhibits Retinal I/R-Induced Vascular Degeneration
Morphology of acellular capillaries after tunicamycin injection was similar to the capillary degeneration found after retinal I/R injury as we reported previously. 4, 7 Since resveratrol has been reported to have vascular protective effects on retinal neovascularization, 29 the possible effect of resveratrol in vascular degeneration after retinal I/R injury was investigated. Seven days after injury, there was a significant increase in the formation of acellular capillaries in I/R-injured retinas compared to that in non-injured retinas ( Fig. 2 , P < 0.01), while there was no significant difference in the number of degenerated capillaries between non-injured and sham operated retinas (Fig. S1C , http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-8406/ -/DCSupplemental). Resveratrol administration (25 mg/kg BW/ day) significantly inhibited I/R injury-induced acellular capillary formation compared to I/R-injured groups (P < 0.01). However, low dosage resveratrol administration (5 mg/kg BW/day) showed no effects on I/R injury-induced acellular capillary formation.
Resveratrol Does Not Prevent Retinal I/R-Induced Neuronal Cell Loss
Neuronal degeneration is another I/R-induced pathological change besides capillary degeneration in the retina. Effects of resveratrol on retinal I/R-induced neuronal cell loss were evaluated by two different methods. Consistent with our previous observations, 4,7 four days after retinal I/R injury there was a significant cell loss in GCL in I/R-injured retinas compared to that in non-injured retinas (P < 0.01, Figs. 3A, 3B), while there was a similar cell number in GCL between non-injured and sham-operated retinas (Fig. S1D , http://www. iovs.org/lookup/suppl/d oi:10.1167/iovs.11-8406/-/ DCSupplemental). However, pre-treatment of neither high nor low dosage of resveratrol significantly inhibited I/R-induced cell loss in GCL (Figs. 3A, 3B) .
To confirm the effect of resveratrol on retinal I/R-induced neurodegeneration, a specific retinal ganglion cell marker was used. Brn3a is a transcription factor expressed specifically in the nuclei of ganglion cells. 30 Representative images of Brn3a immunostaining of each group on retinal flat-mounts with different magnifications were shown in Figure 3C (40· and 100·) and Figure S2 
Resveratrol Inhibits Retinal I/R-Induced UpRegulation of Eukaryotic Translational Initiation Factor 2a (eIF2a)-CHOP Branch of ER Stress
Effects of resveratrol on ER stress were investigated further after retinal I/R injury. Prolonged activation of ER stress results in phosphorylation of eIF2a, which leads to induction of CHOP, which initiates the ER stress-dependent apoptosis. 8 The mRNA and protein levels of CHOP were examined three hours and one day after retinal I/R injury. Similar CHOP and p-eIF2a/ t-eIF2a levels were found in the injured retinas compared to those in the non-injured retinas three hours after the injury (Figs. S3A, S3B, http://www.iovs.org/lookup/suppl/doi:10. 1167/iovs.11-8406/-/DCSupplemental). However, the transcript level of Chop was increased mildly one day after retinal I/R injury (P ¼ 0.08, Figs. 4A, 4B ). In addition to mRNA level, protein level of CHOP was 8-fold increased one day after retinal I/R injury (P < 0.05, Fig. 4B ). Furthermore, p-eIF2a, the upstream factor that induces CHOP elevation, also was increased significantly 5.3-fold one day after I/R injury (P < 0.05, Fig. 4B ). All these changes were inhibited significantly by high dosage of resveratrol pretreatment (P < 0.05, Figs. 4A, 4B). There was no difference in the total eIF2a level among the experimental groups.
To clarify whether resveratrol affects ER stress on vascular part of the retina, CHOP expression on retinal vasculatures of different experimental groups was evaluated. We observed elevated CHOP expression in the nuclei of vascular cells one day after I/R injury, and this injury-induced vascular CHOP overexpression was inhibited significantly by the pretreatment high dosage of resveratrol (Fig. 4C) .
Resveratrol Inhibits Retinal I/R-Induced IRE1a UpRegulation and Xbp1 Splicing
IER1a, another ER stress sensor localized on ER membrane, also was analyzed. Although its level was not changed three hours after the injury (Figs. S3A, S3B , http://www.iovs.org/lookup/ suppl/doi:10.1167/iovs.11-8406/-/DCSupplemental), an 8.1-fold up-regulation of IER1a was triggered one day after I/R injury (P < 0.05). Pretreatment of high dosage of resveratrol inhibited significantly the injury-induced IRE1a overexpression (P < 0.05; Figs. 5A , 5B). No difference was found in the total JNK1/2 levels among the experimental groups one day after the injury. However, one day after retinal I/R injury, a 3.6-fold increase in phosphorylation level of JNK1/2 was observed (P < 0.05), while resveratrol treatment did not inhibit this alternation.
Another possible downstream target of IRE1a activation, Xbp1 splicing, was investigated. Xbp1 splicing, shown as the ratio of Xbp1s/Xbp1t, was increased significantly one day after I/R injury (P < 0.05, Figs. 5C, 5D ). Pretreatment of high dosage of resveratrol inhibited significantly the I/R injury-induced Xbp1 splicing (P < 0.05, Figs. 5C, 5D ).
Resveratrol Inhibits Retinal I/R-Induced Overexpression of Bip
Bip is a molecular chaperone that modulates ER homeostasis and helps protein refolding under stressed conditions. 8 Its protein level was increased mildly three hours after I/R (P ¼ 0.08; Figs. S3A, S3B, http://www.iovs.org/lookup/suppl/doi:10. 1167/iovs.11-8406/-/DCSupplemental), the mRNA and protein levels of Bip also were elevated one day after the injury (P < 0.05 and P ¼ 0.08, respectively, Figs. 6A, 6B), and pretreatment of high dosage resveratrol inhibited the injury-induced increase in Bip mRNA level (P < 0.05) but not the protein level.
Resveratrol Inhibits Tunicamycin-Induced ER Stress in the Retina ER stress markers also were investigated in the retinas after tunicamycin injection. RT-PCR results showed significantly increased mRNA levels of ER stress markers, including Chop, growth arrest and DNA damage-inducible protein 34 (Gadd34), Bip, heat shock protein 70 (Hsp70) and protein disulfide isomerase (Pdi), in tunicamycin injected retinas ( iovs.11-8406/-/DCSupplemental). Western blots demonstrated that 0.1 lg tunicamycin injection triggered significant overexpression of ER stress markers (CHOP, IRE1a, Bip) compared to vehicle-injected retinas, and these increases were inhibited significantly by resveratrol treatment (Fig. 7) .
DISCUSSION
Neuronal and vascular cells are two major targets for retinal damages in various ocular diseases. Neuronal and vascular degeneration has been observed in retinal I/R injury models. 4, 6, 7 Several mechanisms through which retinal I/R injury contributes to neurodegeneration have been demonstrated. 6, [31] [32] [33] However, investigations on the underlying mechanisms of I/R-induced vascular degeneration are lacking. In our study, we demonstrated that tunicamycin injection and retinal I/R injury could induce prolonged ER stress and acellular capillary formation in vivo, and these alternations can be inhibited dramatically by administration of resveratrol, suggesting ER stress might be one contributor to vascular dysfunction after retinal injury. As an important cell type for normal retinal functions, capillary cells can be triggered to death by severe ER stress in vitro. CHOP protein are over-expressed in human retinal capillary endothelial cells when challenged with ER stress inducer or high glucose. 34, 35 Glucose deprivation also induces overexpressions of CHOP and Bip in cultured rat retinal capillary pericytes. 36 However, in vivo data that links ER stress to capillary cell death is missing. Our study demonstrated that tunicamycin could dramatically induce formation of retinal acellular capillary in a dose-dependent manner. Resveratrol treatment significantly suppressed ER stress inducer-induced acellular capillary formation. To our knowledge, this is the first in vivo evidence showing that ER stress contributes to vascular degeneration. However, whether ER stress factors have the casual roles in I/R-induced capillary degeneration still is unclear, and additional experiments that use endothelial cellspecific CHOP knockout mice will be of future interest to understand this issue better.
Involvements of ER stress in retinal diseases have been demonstrated under multiple insults, including NMDA, ER stress inducers, and I/R injury. These insults can trigger CHOP induction, and cause retinal cell death and neurodegeneration. [18] [19] [20] 37, 38 In the chronic glaucoma model caused by cauterizing episcleral veins, elevated CHOP expression and subsequent retinal ganglion cell loss are demonstrated. 14 Furthermore, retinal detachment induces significant increases in CHOP and Bip expression levels, and retinal cell death. 39 In addition, I/R injury induced by central retinal artery occlusion also causes an increase in ER stress-related markers, including IRE1a and phosphorylated JNK1/2 in GCL. 13 Activation of ER stress not only is associated with retinal diseases, but also can be a causative factor in the development of neurodegeneration in the retina, since intravitreal injection of ER stress inducer, such as tunicamycin, induces rapid retinal neurodegeneration. 18, 19 Bip inducer inhibits the CHOP overexpression and, thus, attenuates neurodegeneration in retina injuries induced by NMDA and tunicamycin. 19 Consistent with this, NMDAinduced neurodegeneration is reduced in the mice lacking CHOP. 20 Activation of ER stress also was found in our study using a high ocular pressure-induced I/R injury model, as demonstrated by the significant increase in CHOP, p-eIF2a, Bip, Xbp1 splicing and IRE1a overexpression and JNK1/2 activation (Figs. 4-6) .
The rationale for using resveratrol in our study is due to its vascular protective effects, which have been studied in some ocular diseases. 24, 29 In the endotoxin-induced uveitis model, resveratrol administration leads to suppression of leukocyte adhesion on the retinal vasculature by its anti-oxidative and anti-inflammatory effects in a dose-dependent manner. 24 Oral administration of resveratrol also inhibits the retinal neovascularization via inhibition of vascular endothelial growth factor in Vldlr -/-mice, 29 the mice with very low-density lipoprotein receptor (VLDLR) mutant that have pathologic features similar to macular telangiectasia. 40 In our study, resveratrol attenuates tunicamycin and I/R injury-induced vascular degeneration (Figs. 1, 2) , and a direct effect of resveratrol on I/R-induced vascular CHOP overexpression also is demonstrated (Fig. 4C) , which is consistent with the vascular protective roles of resveratrol.
The effects of resveratrol on ER stress are controversial based on several in vitro studies. After 24 hours of incubation, treatments with 10-100 lM resveratrol have been shown to cause apoptosis, and induce overexpression of CHOP and Bip in cancer cell lines. [41] [42] [43] In contrast, other investigators have demonstrated that in mouse embryonic fibroblasts co-treated with tunicamycin for 6 hours, treatment with 10 lM resveratrol inhibits significantly tunicamycin-induced CHOP and Bip overexpression. 44 However, to our knowledge, the effects of resveratrol on ER stress in rodent models were unclear. In our study, resveratrol inhibited significantly tunicamycin and retinal I/R injury-induced up-regulation of ER stress markers, including CHOP and IRE1a (Figs. 4, 5, 7) . Moreover, retinal I/R and tunicamycin-induced CHOP up-regulation in vascular cells as well as capillary degeneration were blocked by resveratrol treatment, suggesting ER stress might be a direct link between I/R injury and the following capillary degeneration. Therefore, resveratrol probably protects vasculature from degeneration via attenuating ER stress pathways on retinal vessels after I/R injury.
Resveratrol has been reported to have retinal neuroprotective effects. Resveratrol pretreatment at a dosage of 50 mg/kg BW for 5 days prevents light-induced retinal neurodegeneration. 26 Treating the diabetic mice with resveratrol at a dosage of 20 mg/kg BW for 4 weeks inhibits neuronal apoptosis in the retina via stimulating the activity of Ca 2þ /calmodulin-dependent protein kinase II. 28 However, in our study, neither 5 nor 25 mg/ kg BW per day of resveratrol showed protective effects on neurodegeneration after retinal I/R, as indicated by two different methods (Fig. 3) . This difference may be due to, but not limited to, the different dosages of resveratrol and/or the different durations of resveratrol exposure that were used. Under our experimental conditions, the fact that resveratrol inhibits the cell death of retinal capillary cells but not the neuronal cells, at least, suggests vascular and neuronal elements in the retina may be targeted differently by resveratrol. In summary, our study suggested that ER stress contributes to retinal capillary degeneration in vivo. We demonstrated that retinal I/R injury and tunicamycin trigger ER stress activation and subsequent vascular degeneration. Resveratrol suppresses tunicamycin and I/R injury-induced ER stress via inhibition of expressions of CHOP and IRE1a, thus resulting in protection against the injury-induced capillary degeneration (Fig. 8 ). Our study revealed a possible role of ER stress in the development of capillary degeneration, and suggested that resveratrol could be a potential drug candidate for vascular dysfunction in the retina.
